- BrainStorm Cell Therapeutics (NASDAQ:BCLI) pays $600K to repurchase warrants to buy 5M shares of the company's common stock. The transaction was executed in preparation for the firm's uplisting to a national exchange.
BrainStorm repurchases warrants
Recommended For You
About BCLI Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| BCLI | - | - |
| Brainstorm Cell Therapeutics Inc. | ||